Plain-English translation of NCT07253285 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing —a new medication that can be used alone or combined with (a medication already approved for weight management in adolescents and adults)—to help children and teenagers with excess weight lose weight. The study will compare these new treatments to a placebo (a fake injection with no active medicine) to see which works best and how safe they are.
While weight management is increasingly important for children's health, there are limited treatment options available for young people. This medication aims to fill that gap by offering a new tool for families who have already tried diet and exercise changes but haven't seen enough weight loss.
You likely qualify if…
You likely don't qualify if…
If you are chosen for the study, you'll receive an injection once a week for about 1.5 years in the main phase. The dose will be increased gradually over the first few weeks, then kept steady for the rest of the study. You'll have regular visits to check how well the medication is working, measure your weight, and monitor for any side effects. If you do well, you may be invited to continue in an extension phase that lasts up to 5 years total.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United States